Back | Next |
home / stock / hcm / hcm message board
Subject | By | Source | When |
---|---|---|---|
Anyone hear anything lately? Want to see this one go | MWM | investorshub | 04/20/2023 10:56:15 AM |
$HCM oh yeah news for the day | MWM | investorshub | 04/20/2023 10:11:03 AM |
$HCM Price trading | whytestocks | investorshub | 04/19/2023 10:47:54 AM |
$HCM oh yeah news for the day | ultrag | investorshub | 04/19/2023 3:03:20 AM |
Good read | hang ten | investorshub | 04/17/2023 4:24:01 AM |
here we go bulls news is here | Patrickwan1 | investorshub | 04/16/2023 3:26:02 PM |
bears and bulls | MWM | investorshub | 04/16/2023 5:49:28 AM |
The trading | MWM | investorshub | 04/13/2023 10:22:20 PM |
what do you make of this data? | fact4 | investorshub | 04/12/2023 6:08:33 AM |
$HCM The gaining last up | hang ten | investorshub | 04/11/2023 10:20:29 PM |
The now last up | whytestocks | investorshub | 04/10/2023 5:31:04 AM |
$HCM short data if anyone is interested | MWM | investorshub | 04/09/2023 11:46:53 AM |
$HCMC is diluting around 201 billion shares into | crowin | investorshub | 01/14/2021 2:40:42 PM |
News: $HCM Chi-Med's Elunate® (Fruquintinib Capsules) Included in | whytestocks | investorshub | 11/28/2019 3:15:22 PM |
News: $HCM Chi-Med Initiates an International Phase I/Ib | whytestocks | investorshub | 10/04/2019 12:30:20 PM |
News: $HCM Edison Issues ADR Outlook on Hutchison | whytestocks | investorshub | 07/05/2019 2:34:23 PM |
Crazy pump. | Patrickwan1 | investorshub | 03/15/2017 4:31:27 PM |
50 for 1 R/S | MWM | investorshub | 03/28/2009 5:28:48 PM |
Form 8-K for WALTER INDUSTRIES INC /NEW/ | MWM | investorshub | 02/15/2009 9:00:44 PM |
I had forgotten about this one thanks! | MWM | investorshub | 01/09/2009 4:49:46 PM |
News, Short Squeeze, Breakout and More Instantly...
HUTCHMED (China) Limited Company Name:
HCM Stock Symbol:
NASDAQ Market:
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based on results from FRESCO-2 Phase III clinical trial — ...
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; ...
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the ...